Asymptomatic factor VII deficiency: Gene analysis and structure-function relationships

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 1, 2010, Pages 91-94

  Kirkel, Dean ^a   Lin, Ta Wei ^b   Fu, Sidney W ^b   Dlott, Jeffrey S ^c   Sahud, Mervyn A ^c   McCaffrey, Timothy ^b   Rickles, Frederick R ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Department of Biochemistry and Molecular Biology   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Asymptomatic factor VII deficiency; Coagulation; Factor VII deficiency; Factor VII Padua; Molecular diagnostics; Transfusion medicine

Indexed keywords

BLOOD CLOTTING FACTOR 7; THROMBOPLASTIN;

ADULT; AFRICAN AMERICAN; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HUMAN; MISSENSE MUTATION; PRIORITY JOURNAL; PROTHROMBIN TIME; STRUCTURE ACTIVITY RELATION;

ANIMALS; DNA MUTATIONAL ANALYSIS; FACTOR VII; FACTOR VII DEFICIENCY; FACTOR VIII; FEMALE; GASTRIC BYPASS; HUMANS; INCIDENTAL FINDINGS; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PREOPERATIVE CARE; PROTHROMBIN TIME; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP; SURGICAL PROCEDURES, ELECTIVE;

EID: 75649113859     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328331e708     Document Type: Article

References (20)

1. Alexander B, Goldstein R, Landwehr G, Cook CD. Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J Clin Invest 1951; 30:596-608.
2. Acharya SS, Coughlin A, DiMichele DM, North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2:248-256.
3. Pollak ES, Russell TT, Ptashkin B, Smith-Whitley K, Camire RM, Bauer KA. Asymptomatic factor VII deficiency in African Americans. Am J Clin Pathol 2006; 126:128-132.
4. McVey JH, Boswell E, Mumford AD, Kemball-Cook G, Tuddenham EGD. Factor VII deficiency and the FVII mutation database. Hum Mutat 2001; 17:3-17.
5. Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985; 66:1284-1287.
6. Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A. Factor II Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978; 91:387-395.
7. Radcliffe R, Bagdasarian A, Colman R, Nemerson Y. Activation of bovine factor VII by Hageman factor fragments. Blood 1977; 50:611-617.
8. James HL, Girolami A, Hubbard JG, Kumar A, Fair DS. The dysfunction of coagulation factor VII Padua results from substitution of arginine-304 by glutamine. Biochim Biophys Acta 1993; 1172:301-305.
9. Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C, Jeanjean P, Igual H, Schved JF, Study Group of Factor Seven Deficiency. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001; 9:105-112.
10. Horellou MH, Chalendard J, Juin F, Conard J, Gouault-Heilmann M, Tapon- Bretaudiè re J. Source of tissue factor leading to discrepant plasma FVII levels in eight FVII-deficient patients of African origin [abstract]. J Thromb Haemost 2007; 5 (Suppl 2):P-M-002.
11. Bernardi F, Castaman G, Pinotti M, Ferraresi P, Di Iaso MG, Lunghi B, et al. Mutation pattern in clinically asymptomatic coagulation factor VII deficiency. Hum Mutat 1996; 8:108-115.
12. Krauss JS, Matthews A, Oliver J, Lightsey A, Jonah MH, Pantazis CG. African-American factor VII-deficient variants in Georgia (FVII variants). Am J Hematol 1994; 47:239-241.
13. Furlan Freguia C, Toso R, Pinotti M, Gemmati D, Bernardi F. Comparison among natural (Arg304Gln, Arg304Trp) and artificial (Arg290His, Arg290Lys) mutations in coagulation factor VII loops. J Thromb Haemost 2003; 1:2455-2457.
14. Dickinson CD, Kelly CR, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Nat Acad Sci U S A 1996; 93:14379-14384.
15. Arbini AA, Pollak ES, Bayleran JK, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter. Blood 1997; 89:176-182.
16. Carew JA, Pollak ES, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter. Blood 1998; 92:1639-1645.
17. Nagaizumi K, Inaba H, Suzuki T, Hatta Y, Hagiwara T, Amano K, et al. Two double heterozygous mutations in the F7 gene show different manifestations. Br J Haematol 2002; 119:1052-1058.
18. Fromovich-Amit Y, Zivelin A, Rosenberg N, Tamary H, Landau M, Seligsohn U. Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost 2004; 2:1774-1781.
19. Bernardi F, Patracchini P, Gemmati D, Ferrati M, Arcieri P, Papacchini M, et al. Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region. Hum Genet 1993; 92:446-450.
20. Wulff K, Herrmann FH. Twenty two novel mutations of the factor VII gene in factor VII deficiency. Hum Mutat 2000; 15:489-496.